Clinical trial

Targeted Ultrasound in Rheumatoid Arthritis

NCT02056184

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-12-01

PhasePHASE4

Study timeline

Study start (actual)2013-12-01Date precision: month

Registry last updated2019-10-31

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Targeted Ultrasoundunresolved

Interventions

AdalimumabDRUG · verified · RxNorm: adalimumab

Sponsors & collaborators

University of Leedslead sponsor

AbbViecollaborator

Theoremcollaborator

Mapped research locations

LeedsUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02056184 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.